Listen to Medscape InDiscussion: Endometrial Cancer, a podcast series where thought leaders and clinical experts share their diverse insights and practical ideas for optimizing patient care. Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s1-ep1-2026a10007qe. The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
What Can Risk Factors Teach Us About Endometrial Cancer?
Drs Ursula A. Matulonis and Immaculata De Vivo discuss the epidemiology of endometrial cancer and how clinicians can use information about risk factors.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s3-ep6-2026a10006ig (https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s3-ep6-2026a10006ig). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Endometrial Carcinoma https://emedicine.medscape.com/article/254083-overview (https://emedicine.medscape.com/article/254083-overview)
Cancer Stat Facts: Uterine Cancer https://seer.cancer.gov/statfacts/html/corp.html (https://seer.cancer.gov/statfacts/html/corp.html)
Risk Prediction Models for Endometrial Cancer: Development and Validation in an International Consortium https://pubmed.ncbi.nlm.nih.gov/36688725/ (https://pubmed.ncbi.nlm.nih.gov/36688725/)
Genome-wide Association Study of Endometrial Cancer in E2C2 https://pubmed.ncbi.nlm.nih.gov/24096698/ (https://pubmed.ncbi.nlm.nih.gov/24096698/)
Projected Trends in the Incidence and Mortality of Uterine Cancer in the United States https://pubmed.ncbi.nlm.nih.gov/40589281/ (https://pubmed.ncbi.nlm.nih.gov/40589281/)
Understanding Risk Factors for Endometrial Cancer in Young Women https://pubmed.ncbi.nlm.nih.gov/39235934/ (https://pubmed.ncbi.nlm.nih.gov/39235934/)
Association Between Metabolic Syndrome and Endometrial Cancer Risk: A Systematic Review and Meta-analysis of Observational Studies https://pubmed.ncbi.nlm.nih.gov/32439832/ (https://pubmed.ncbi.nlm.nih.gov/32439832/)
Cigarette Smoking and Endometrial Cancer Risk: Observational and Mendelian Randomization Analyses https://pubmed.ncbi.nlm.nih.gov/35900194/ (https://pubmed.ncbi.nlm.nih.gov/35900194/)
Physical Activity and Risk of Endometrial Adenocarcinoma in the Nurses' Health Study https://pubmed.ncbi.nlm.nih.gov/24213924/ (https://pubmed.ncbi.nlm.nih.gov/24213924/)
Hysterectomy-Corrected Uterine Corpus Cancer Incidence Trends and Differences in Relative Survival Reveal Racial Disparities and Rising Rates of Nonendometrioid Cancers https://pubmed.ncbi.nlm.nih.gov/31116674/ (https://pubmed.ncbi.nlm.nih.gov/31116674/)
Type I and II Endometrial Cancers: Have They Different Risk Factors? https://pubmed.ncbi.nlm.nih.gov/23733771/ (https://pubmed.ncbi.nlm.nih.gov/23733771/)
Differential Trends in Rising Endometrial Cancer Incidence by Age, Race, and Ethnicity https://pubmed.ncbi.nlm.nih.gov/36625534/ (https://pubmed.ncbi.nlm.nih.gov/36625534/)
Harvard Radcliffe Institute. Podcast Episode 208: Kindness—It’s Good for You! December 12, 2024. Interview with Immaculata De Vivo and Daniel Lumera, authors of “The Biology of Kindness: Six Daily Choices for Health, Well-Being, and Longevity.” Accessed May 13, 2026. https://www.radcliffe.harvard.edu/news-and-ideas/episode-208-kindness-it-s-good-for-you (https://www.radcliffe.harvard.edu/news-and-ideas/episode-208-kindness-it-s-good-for-you)
Research Project—Cooperative Agreements (U01) https://grants.nih.gov/funding/activity-codes/u01 (https://grants.nih.gov/funding/activity-codes/u01)
Center for Inherited Disease Research https://cidr.jhmi.edu/ (https://cidr.jhmi.edu/)
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.
2 Jul 2026
The Future of Endometrial Cancer Pathology
Drs Ursula A. Matulonis and Marisa R. Nucci discuss the future of AI and pathology and how genetics and genomics play a role in the diagnosis of endometrial cancer.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s3-ep5-2026a10006if (https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s3-ep5-2026a10006if). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Endometrial Carcinoma https://emedicine.medscape.com/article/254083-overview (https://emedicine.medscape.com/article/254083-overview)
WHO Classification of Tumours Online https://tumourclassification.iarc.who.int/welcome/ (https://tumourclassification.iarc.who.int/welcome/)
The Cancer Genome Atlas Program (TCGA) https://www.cancer.gov/ccg/research/genome-sequencing/tcga (https://www.cancer.gov/ccg/research/genome-sequencing/tcga)
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives https://pubmed.ncbi.nlm.nih.gov/36232987/ (https://pubmed.ncbi.nlm.nih.gov/36232987/)
FIGO Staging of Endometrial Cancer: 2023 https://pubmed.ncbi.nlm.nih.gov/37337978/ (https://pubmed.ncbi.nlm.nih.gov/37337978/)
The Desert Immune Phenotype in Endometrial Carcinoma: A Distinct Subgroup With Poor Prognosis and Targetable Mutations https://pubmed.ncbi.nlm.nih.gov/41967711/ (https://pubmed.ncbi.nlm.nih.gov/41967711/)
Controversies in the Management of Serous Tubal Intra-Epithelial Carcinoma Lesions of the Fallopian Tube https://www.international-journal-of-gynecological-cancer.com/article/S1048-891X(25)00192-6/fulltext (https://www.international-journal-of-gynecological-cancer.com/article/S1048-891X(25)00192-6/fulltext)
Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer https://pubmed.ncbi.nlm.nih.gov/41643197/ (https://pubmed.ncbi.nlm.nih.gov/41643197/)
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal From the Italian Study Group https://pubmed.ncbi.nlm.nih.gov/35463299/ (https://pubmed.ncbi.nlm.nih.gov/35463299/)
Application of Artificial Intelligence in Gynecologic Cancers: A Bibliometric Analysis https://pubmed.ncbi.nlm.nih.gov/41585300/ (https://pubmed.ncbi.nlm.nih.gov/41585300/)
Uterine Leiomyosarcoma https://pubmed.ncbi.nlm.nih.gov/35173990/ (https://pubmed.ncbi.nlm.nih.gov/35173990/)
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.
3 Jun 2026
From Carcinosarcoma to Circulating Tumor DNA: The Importance of Investigator-Initiated Research in Endometrial Cancer
Drs Ursula A. Matulonis and Stephanie Lheureux discuss the importance of investigator-initiated clinical trials in endometrial cancer, research on carcinosarcoma, and ctDNA.
Relevant disclosures can be found with the episode show notes on Medscape https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s3-ep4-2026a10006ie (https://www.medscape.com/ca8/p04/podcast-endometrial-cancer-s3-ep4-2026a10006ie). The topics and discussions are planned, produced, and reviewed independently of advertisers. This podcast is intended only for US healthcare professionals.
Resources
Endometrial Carcinoma https://emedicine.medscape.com/article/254083-overview (https://emedicine.medscape.com/article/254083-overview)
Advances in Antibody-Drug Conjugates for Endometrial Cancer https://pubmed.ncbi.nlm.nih.gov/40111079/ (https://pubmed.ncbi.nlm.nih.gov/40111079/)
TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives https://pubmed.ncbi.nlm.nih.gov/36232987/ (https://pubmed.ncbi.nlm.nih.gov/36232987/)
Translational Randomized Phase II Trial of Cabozantinib in Combination With Nivolumab in Advanced, Recurrent, or Metastatic Endometrial Cancer https://pubmed.ncbi.nlm.nih.gov/35288469/ (https://pubmed.ncbi.nlm.nih.gov/35288469/)
Elucidating Divergent Biology in Uterine Carcinosarcoma https://pubmed.ncbi.nlm.nih.gov/40850250/ (https://pubmed.ncbi.nlm.nih.gov/40850250/)
The Immune Microenvironment in Endometrial Carcinoma: Mechanisms and Therapeutic Targeting https://pubmed.ncbi.nlm.nih.gov/40746533/ (https://pubmed.ncbi.nlm.nih.gov/40746533/)
Epithelial-Mesenchymal Transition Orchestrates Tumor Microenvironment: Current Perceptions and Challenges https://pubmed.ncbi.nlm.nih.gov/40176117/ (https://pubmed.ncbi.nlm.nih.gov/40176117/)
Comparative Modeling of Recent and Projected Trends in the Incidence and Mortality of Uterine Cancer https://pubmed.ncbi.nlm.nih.gov/41643197/ (https://pubmed.ncbi.nlm.nih.gov/41643197/)
Genomic Landscape of ctDNA and Real-World Outcomes in Advanced Endometrial Cancer https://pubmed.ncbi.nlm.nih.gov/39417689/ (https://pubmed.ncbi.nlm.nih.gov/39417689/)
Targeting CDK2 for Cancer Therapy https://pubmed.ncbi.nlm.nih.gov/40802510/ (https://pubmed.ncbi.nlm.nih.gov/40802510/)
PYNNACLE Phase II Trial Assessing Rezatapopt (PC14586), a Selective p53 Reactivator, in Patients With Locally Advanced or Metastatic Solid Tumors Harboring a TP53 Y220C Mutation https://www.gynecologiconcology-online.net/article/S0090-8258%2825%2900347-6/abstract (https://www.gynecologiconcology-online.net/article/S0090-8258%2825%2900347-6/abstract)
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com (https://pcm.adswizz.com) for information about our collection and use of personal data for advertising.
Reach and audience
Public platform figures. Ratings count people who left a rating, not total listeners.
YouTube views
27,323,396
Score snapshot 15 Sept 2025
Apple Podcasts (US)
5.0 / 5
1 ratings
Podcast Authority Score: 46 / 100
A composite of feed quality, social presence, YouTube performance and engagement. Read the methodology.
Quality
55
Social presence
0
YouTube
93
Engagement
0
Contact Medscape InDiscussion: Endometrial Cancer
Guest appearances
Books guests
Based on episode analysis; this does not confirm that the show is currently accepting guests.
Host of Medscape InDiscussion: Endometrial Cancer?
Claim your podcast to manage its listing and keep your show details accurate.
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
